The C fragment of tetanus neurotoxin (TeNT-Hc) with different conformations was observed due to the four cysteine residues within it which could form different intramolecular disulfide bonds. In this study, we prepared and compared three types of monomeric TeNT-Hc with different conformational components: free sulfhydryls (50 kDa), bound sulfhydryls (44 kDa 
There are an estimated 250,000 tetanus cases every year, and the majority of them are neonatal tetanus (2) . Current tetanus vaccines are based on inactivated tetanus toxin and are extremely effective in protecting against the highly potent neurotoxin released upon infection by Clostridium tetani (4) . However, the existing tetanus toxoid vaccine has many drawbacks due to its side effects, dangers during production, and the pollution caused by formaldehyde, etc. The C fragment of tetanus neurotoxin (TeNT-Hc), which retains full binding affinities to neuronal cells via gangliosides in lipid rafts (13, 16, 17) , shows considerable promise as a possible next-generation subunit vaccine against tetanus (7, 10) .
In our previous work, the nontagged TeNT-Hc got excellent expression in Escherichia coli BL21(DE3) and could be purified to produce large quantities of product with the potential of being used in the human body as a candidate tetanus vaccine (18) . Interestingly, when detected by nonreducing SDS-PAGE, the purified TeNT-Hc could migrate from one band of 50 kDa to double bands of 50 kDa and 44 kDa when stored at 4°C or room temperature for several days in phosphate-buffered saline (PBS) buffer. The proportion of the 44-kDa band could increase gradually to almost 100% and then retain a stable state. When detected by reducing SDS-PAGE, the purified TeNT-Hc always ran as a stable single band of 50 kDa no matter how long the storage period was. This phenomenon was basically consistent with a former report (11) : there are four cysteine residues within the TeNT-Hc fragment, and at least two of these, Cys 869 and Cys 1093 , have been confirmed to form an intramolecular disulfide bond (7, 8, 9) .
The purified recombinant TeNT-Hc has two monomeric forms: bound sulfhydryls (44 kDa) and free sulfhydryls (50 kDa). The expressed TeNT-Hc does not have enough time to form the disulfide bonds during the expression and purification, and it takes several days to change from one conformation (50 kDa) to another (44 kDa). We wanted to determine whether the conformational changes in TeNT-Hc resulting from disulfide bond formation can affect its characterization and immunogenicity and which monomeric conformational form is the better subunit vaccine candidate against tetanus.
In this report, we prepared and compared three types of TeNT-Hc with different conformational components: free sulfhydryls (50 kDa), bound sulfhydryls (44 kDa), and a mixture of the two conformational proteins (half 50 kDa and half 44 kDa). We detected their binding activity to ganglioside G T1b and neuronal PC-12 cells and we also compared their immunogenicities, antibody types induced, and protective capacities against tetanus toxin challenge in mice. Our results showed that the conformational changes of the C fragment of tetanus neurotoxin (TeNTHc) resulting from disulfide bond formation reduced the ganglioside-binding activity but did not destroy its immunogenicity as a potent vaccine candidate; that is, the presence of the gangliosidebinding site within TeNT-Hc may be not essential for the induction of a fully protective antitetanus response.
MATERIALS AND METHODS
Preparation of different conformations of TeNT-Hc proteins. The TeNT-Hc protein was expressed in E. coli BL21(DE3) and purified as described before (18) . This purified TeNT-Hc had free sulfhydryls and was named TeNT-Hc 1#. Protein TeNT-Hc 1# was restored at 4°C for 96 h, and the protein changed to a mixture of the two conformational proteins-half 50 kDa and half 44 kDawhich was named TeNT-Hc 2#. After continuous restoration at 4°C for another 96 h, the intramolecular disulfide bonds could form thoroughly, and the protein was seen as a 44-kDa band and named TeNT-Hc 3#. These three types of TeNT-Hc with different conformational components were detected by reducing and nonreducing SDS-PAGE. In the reducing condition, proteins were heated to near boiling in the presence of dithiothreitol (DTT), a reducing agent which further denatures the proteins by reducing disulfide linkages. In the nonreducing condition, there was no boiling, no reducing agent was added, and the proteins all retained native structures. All the proteins were divided into small aliquots and stored at Ϫ80°C.
Ganglioside-binding ELISA. The different conformational TeNT-Hc binding activities to ganglioside G T1b were measured with enzyme-linked immunosorbent assay (ELISA). Ninety-six-well plates were coated with 100 l of 2 g/ml G T1b (Sigma) in methanol, and plates were left at room temperature overnight to allow methanol to evaporate. After the ganglioside G T1b -coated wells were washed with PBS-Tween (PBST), 100 l of 20-g/ml or 10-g/ml TeNT-Hc 1#, 2#, and 3# proteins were then added to wells in triplicate and incubated for 1 h at 37°C separately. Plates were washed 4 times in PBST and incubated for 1 h at room temperature with 1:5,000 of diluted goat antitetanus toxoid polyclonal antibody (Abcam) at 100 l/well. The plates were washed with PBST and then incubated with a 1:5,000 dilution of peroxidase-labeled rabbit anti-goat IgG antibody (Abcam) for 1 h at 37°C. Plates were washed and detected at 450 nm after the addition of tetramethylbenzidine (TMB) (Sigma).
PC-12 cell binding assay by FACS. Protein TeNT-Hc 1#, 2#, and 3# used in this assay were all prelabeled by Alexa Fluor 488 dye by using a Alexa Fluor 488 protein labeling kit (Invitrogen) according to the kit protocol. Rat pheochromocytoma (PC-12) cells (purchased from Shanghai Institute of Cell Biology, China) were grown in 1640 medium containing 4 mg/liter of glucose supplemented with 10% fetal calf serum, 5% horse serum, 100 g/ml penicillin, 100 g/ml streptomycin, and 4 mM L-glutamine. The nerve growth factor (NGF; 100 ng/ml, 2.5S) (Sigma) was added to the cell culture for about 2 days to induce the differentiation of PC-12 cells. The Alexa Fluor 488 dye-labeled TeNT-Hc 1#, 2#, and 3# proteins were diluted to 20 g/ml in PBS containing 3% bovine serum albumin (BSA) and 10% fetal calf serum and were incubated with PC-12 cells for 1 h at 4°C. Cells were washed 3 times in PBS (500 ϫ g, 5 min/time) and resuspended in 300 l of PBS. The cells were analyzed with a Becton Dickinson fluorescenceactivated cell sorter (FACS) (BD Biosciences) at 30,000 events/sample with respect to unlabeled cells. The data were analyzed using CellQuest (Becton Dickinson).
Vaccination of mice. Six-to 8-week-old female BALB/c mice (purchased from Beijing Laboratory Animal Center, China) were used in this study, and every six mice were classified in one group. Each BALB/c mouse received an intraperitoneal (i.p.) injection of 10 g of TeNT-Hc 1#, 2#, and 3# and 0.75 mg of Al(OH) 3 adjuvant (Brenntag Biosector, Denmark) in 0.5 ml of normal saline solution (NS). All the mice received 3 vaccinations on days 0, 14, and 28. Serum samples were collected from tails at weeks 2, 4, 6, 10, 15, 18, and 24. One group of mice was injected by PBS and the adjuvant as a negative control.
Serological analysis of total IgG. Using a formalin-inactivated tetanus toxoid (provided by Shumin Zhang, National Institute for the Control of Pharmaceutical and Biological Products) as the solid-phase antigen to measure the titer of the antibody induced by TeNT-Hc 1#, 2#, and 3# immunization, 96-well plates (Costar) were coated with 1 g/ml of antigen in PBS at 4°C and incubated overnight. Then, they were blocked for 1 h with 3% BSA. The serum samples collected from mice were series diluted from 1:200 to 1:409,600 in PBS and then added to the plate and incubated for 2 h at 37°C. The plates were washed with PBST and then incubated with a 1:5,000 dilution of peroxidase-labeled goat anti-mouse total IgG antibody (Abcam) for 1 h at 37°C. The plates were washed again, and the peroxidase substrate, tetramethylbenzidine (TMB; Sigma), was added to each well and incubated at room temperature. The TMB reaction was stopped with 2 M H 2 SO 4 , and the absorbance at 450 nm was read with a microplate reader (Bio-Rad).
Quantitative determination of IgG isotyping. The concentrations of IgG1 and IgG2a subclasses in the serum samples collected from mice vaccinated by TeNT-Hc 1#, 2#, or 3# were determined respectively using an IgG1 (mouse) enzyme immunoassay (EIA) kit (Enzo Life Sciences) and an IgG2a (mouse) EIA kit (Enzo Life Sciences). The operations were all according to the experimental protocol of the kits.
Challenge of animals long after vaccinations. Mice which were immunized 3 times were challenged with tetanus neurotoxin (provided by Shumin Zhang, National Institute for the Control of Pharmaceutical and Biological Products) at 24 weeks after the first vaccination by subcutaneous injection of 2 ϫ 10 3 50% lethal doses (LD 50 s) of toxin with a volume of 0.5 ml in borate-buffered saline (0.5 g of borax, 4.5 g of boric acid, and 8.5 g of sodium chloride in 1 liter of distilled water). Mice were observed for 10 days, and those alive were scored as survivors.
Potency comparison of low doses of TeNT-Hc vaccine. The TeNT-Hc 1#, 2#, and 3# protein (final concentration of 20 g/ml) was added to the Al(OH) 3 gel adjuvant (final concentration of 1.5 mg/ml). After overnight adsorption at 4°C, the vaccines were 120-fold diluted with normal saline. BALB/c mice were used in this study, and groups were comprised of 5 male and 5 female mice (total, 10 mice per group). Each mouse received an abdominal subcutaneous injection of diluted TeNT-Hc human vaccines in 0.5-ml portions. Four weeks after the vaccination, mice were challenged with 50 LD 50 s of tetanus neurotoxin and were observed for 10 days, and those alive after that time were scored as survivors.
Data analysis. Statistical calculations were performed using SPSS 10.0 for Windows (SPSS Inc., Chicago, IL). For the samples tested individually, data were expressed as the mean Ϯ standard deviation (SD). Student's t test was applied to determine the significance of the difference between two independent data, and the paired t test was used to determine the group differences. Comparisons among the groups were also made using the Mann-Whitney test. Survival curves were compared using a log rank (Mantel-Cox) test. A two-sided P value of Ͻ0.05 was considered statistically significant.
RESULTS
Binding activities of different conformations of TeNT-Hc to ganglioside G T1b . Three types of TeNT-Hc with different conformational components (Fig. 1) were prepared, and G T1b binding activities were detected with ELISA. As the results show (Fig. 2) , there were significant differences among the three types of protein (P Ͻ 0.05) with either 20 g/ml or 10 g/ml. TeNT-Hc 1# with the free sulfhydryls had the highest binding activity, and TeNT-Hc 3# with bound sulfhydryls had a significantly reduced ability to bind to G T1b , which was about 7 times lower than TeNT-Hc 1# did, while TeNT-Hc 2# was between them.
PC-12 cell binding activities. TeNT-Hc could bind to NGFtreated neuronal PC-12 cells, which were established from a rat pheochromocytoma and had many properties in common with primary sympathetic neurons. The differences among the three types of TeNT-Hc which were prelabeled by Alexa Fluor 488 dye were assayed by FACS. As the results show (Fig. 3) , TeNT-Hc 1# had the highest binding activity to differentiated PC-12 cells with the strongest fluorescence, while TeNT-Hc 2# and TeNT-Hc 3# had reduced binding activities. This result was consistent with the result of the G T1b assay.
Immunogenicity of three different conformations of TeNTHc. Groups of six mice were immunized by i.p. injections with TeNT-Hc 1#, 2# or 3#, proteins absorbed by Al(OH) 3 adjuvant at weeks 0, 2, and 4. Mice were periodically blood sampled through the tail vein. Tetanus toxoid-specific IgG responses were determined with ELISA, and then a comparison was made among the means of the groups receiving different conformational TeNT-Hc vaccines over a time course of 24 weeks (Fig. 4 ). There were detectable levels of IgG against tetanus toxoid at 2 weeks after primary immunization in mice, which peaked at 6 weeks after boost. These titers were maintained for over half a year. All the three vaccines could elicit antibody titers as strong as 1:200,000 against tetanus toxoid in mice after immunization three times. The IgG titers elicited by TeNT-Hc 3# were a little higher than those seen for TeNT-Hc 1# and 2#, but there was no significant difference among them during the monitoring period (P Ͼ 0.05) except at the 4-week time point (P Ͻ 0.05).
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IgG isotyping. Studies were performed to detect the concentration of IgG1 and IgG2a in serum of mice immunized by TeNT-Hc 1#, 2#, or 3# from week 2 to week 24. As the results show (Fig. 5) , the major IgG subclass induced by TeNT-Hc immunization was IgG1, which peaked at week 10 with concentrations of more than 6 mg/ml. TeNT-Hc 3# could elicit IgG1 titers a little higher than those of the other two proteins, but there was no significant difference among them during the monitoring period (P Ͻ 0.05), except at the 4-week time point (P Ͼ 0.05). The IgG1 concentrations elicited by the three vaccines maintained at up to 5 mg/ml during the whole observation period. All three different conformational TeNT-Hc vaccines could also elicit low concentrations of IgG2a antibodies, and the ratios of IgG1 to IgG2a were also studied. Comparison among the three groups shows there was no significant difference in terms of IgG subclass inducement.
In vivo protection against tetanus neurotoxin. The mice vaccinated with a dose of 20 g/ml TeNT-Hc and 1.5 mg/ml Al(OH) 3 adjuvant three times were challenged with tetanus neurotoxin at week 24, and protection was evaluated. When challenged with 2 ϫ 10 3 LD 50 s of tetanus neurotoxin, the three TeNT-Hc vaccines with different conformations all provided excellent protection. All the mice immunized with TeNT-Hc 1#, 2#, and 3# survived, while all the mice immunized with PBS died in 48 h (Table 1) .
Potency comparison of low-dose TeNT-Hc vaccines.
Since all three TeNT-Hc vaccines with normal doses could provide excellent protection against tetanus neurotoxin, a potency comparison of low-dose vaccines with less immunization time was studied. Each group of mice was immunized once with a 120-fold-diluted normal-dose vaccine with a protein dosage of 83 ng/ml. All the mice including a group vaccinated by PBS were challenged with 50 LD 50s of tetanus neurotoxin 4 weeks after immunization. As shown in Fig. 6 , the PBS and TeNT-Hc 1#, 2#, and 3# groups had 0%, 20%, 20%, and 30% protection of mice, respectively. The survival rates of the TeNT-Hc 1#, 2#, and 3# were significantly different from that for the PBS group The binding activities of 20 g/ml and 10 g/ml TeNT-Hc 1#, 2#, and 3# to GT1b was detected by using a goat antitetanus toxoid polyclonal antibody and a rabbit polyclonal secondary antibody to goat. Each point is the average of three wells. The error bars represent ϮSD. Student's t test was employed to assess the statistical significance of difference among different conformations of TeNT-Hc. A two-sided P value of Ͻ0.05 was considered statistically significant.
FIG. 3. Binding activities of
TeNT-Hc 1#, 2#, and 3# to PC-12 cells measured by FACS. TeNT-Hc 1#, 2#, and 3# proteins used in this assay were all prelabeled by Alexa Fluor 488 dye, and the unlabeled cells were used as a negative control.
(P Ͻ 0.05); however, there was no significant difference among the three groups of TeNT-Hc (P Ͼ 0.05).
DISCUSSION
The genetic recombinant TeNT-Hc vaccine is nontoxic and has been studied as a potential candidate for a vaccine against tetanus. This type of vaccine has advantages over traditional toxin-inactivated vaccines in that it is cheaper and less hazardous to produce and can be generated in large quantities. To ensure efficacy, it is crucial to ensure the quality, the batch-tobatch consistency, and the stability of the vaccines from each manufacturer. Since there were conformational changes of TeNT-Hc during the storage at 4°C or room temperature, it is important to study the influence of its immunogenicity as a candidate vaccine against tetanus. As the results of our study have shown, the conformational changes of TeNT-Hc resulting from disulfide bond formation just reduced its binding activities to ganglioside G T1b and neuronal PC-12 cells, while no significant difference in immunogenicity was observed. So, the different conformational components in TeNT-Hc protein from batches may not be the key standard for the vaccine quality.
Since it is commonly accepted that Th1 and Th2 cells induce antigen-specific B cells to selectively produce IgG2a and IgG1, respectively (15), we determined the subclass distribution of serum IgG response in mice immunized by the three different conformations of TeNT-Hc. Analysis of the serum IgG subclasses showed that the IgG1 subclass was predominant after immunization (IgG1:IgG2a ratio, Ͼ30), and there was no significant difference among the three groups. These results showed that conformational changes of TeNT-Hc resulting from storage did not affect the B cell and T cell epitopes, which were essential for the immunogenicity.
TeNT binds initially to complex gangliosides of the 1b series, most notably G T1b and G D1b , tri-and disialogalactosyl biantennary gangliosides that are expressed at high density on neuronal tissue. This binding is mediated solely by TeNT-Hc (3, 6, 8, 9, 14) , and our study has confirmed it. TeNT-Hc 1# with free sulfhydryls can strongly bind to G T1b and NGFtreated PC-12 cells, and this binding activity was significantly reduced during the disulfide bond formation, which means the ganglioside-binding site within TeNT-Hc had been changed. The quantities of IgG1 and IgG2a were determined by ELISA using an IgG1 (mouse) EIA kit and an IgG2a (mouse) EIA kit, respectively. Each point represents the average of six mice. Student's t test was employed to assess the statistical significance of difference between two independent sets of data, and the paired t test was used to determine the group differences. Comparisons among the groups were also made using the Mann-Whitney test. A two-sided P value of Ͻ0.05 was considered statistically significant. a The TeNT-Hc human vaccine was prepared with 20 g/ml of purified TeNT-Hc protein and 1.5 mg/ml Al(OH) 3 gel adjuvant.
b The mice were vaccinated at weeks 0, 2, and 4. c All the mice were challenged with tetanus neurotoxin at weeks 24 after the first vaccination.
d Mice were observed for 10 days, and those alive were scored as survivors.
Qazi et al. (12) argued that mutants of TeNT-Hc containing deletions essential for ganglioside binding elicited lower than those of wild-type TeNT-Hc, and they concluded that the presence of the ganglioside-binding site within TeNT-Hc may be essential for induction of a fully protective antitetanus response compared with that induced by tetanus toxoid. However, our results were not consistent with those in the report of Qazi et al.: the reduction of ganglioside-binding activity resulting from disulfide bond formation did not destroy TeNT-Hc immunogenicity as a potent vaccine candidate. The reasons for the two different conclusions may be that in the study of Qazi et al., the mutants of TeNT-Hc prepared by amino acid deletions or substitutions within the ganglioside-binding site were likely also changed by the conformations of essential peptides which were responsible for the immunogenicity of TeNT-Hc. In our study, the reduction of ganglioside binding was caused by disulfide bond formation, which did not affect the key amino acids to elicit strong antibody response and provide excellent protection against tetanus neurotoxin. The relationships between the conformations of the ganglioside-binding site and the immunogenicity of TeNT-Hc need demonstration through further studies.
TeNT-Hc, which has been considered to be a replacement of tetanus toxoid vaccine, can bind to neuronal cells and is trafficked to higher centers in the central nervous system via retrograde axonal transport (1, 5) . While this does not appear to give rise to any obvious pathology, it would be highly preferable to use an antigen that lacked this activity and thus reduce any potential side effects if the protein were to be used as a human vaccine (12) . It is our opinion that TeNT-Hc 3# protein, which is stable at 4°C and has lower G T1b binding activity and higher immunogenicity, may be developed into an ideal subunit vaccine candidate against tetanus.
Overall, the results of our study may help to enhance the understanding of the immunological mechanism of the TeNT-Hc antigen and to provide a theoretical basis and evaluation criteria for designing new subunit vaccines and epitope vaccines against tetanus. FIG. 6 . Efficacy of immunization with low doses of different conformations of TeNT-Hc against 50-LD 50 tetanus neurotoxin challenge in BALB/c mice. The normal-dose vaccines, which contained 20 g/ml of purified TeNT-Hc 1#, 2#, or 3# protein and 1.5 mg/ml Al(OH) 3 gel adjuvant, were 120-fold diluted with normal saline and used to immunize the mice once at a volume of 0.5 ml. All the mice were challenged with 50 LD 50 s of tetanus neurotoxin in 0.5 ml of normal saline 4 weeks after the vaccination. The animals that died within 10 days after challenge were recorded. Survival curves were compared using a log rank (Mantel-Cox) test. A two-sided P value of Ͻ0.05 was considered statistically significant.
